$PPCB Propanc Biopharma, Inc. Insider Trading
Get free email notifications about insider trading in Propanc Biopharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Propanc Biopharma, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Propanc Biopharma, Inc. for free.
CIK Number: 0001517681
IRS Number: 300662986
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: PPCB
Company Address: 302/6 BUTLER STREET CAMBERWELL, VICTORIA 3124
Phone number: 613-9882-6723
Former name: Propanc Health Group Corp, date of change: 2011-04-08
Former name: Propanc Health Group Corporation
Market Capitalization: $9.25M
Prev close: $0.01
Average Daily Volume: 6,373,560
Days Low: $0.01
Year Low: $0.01
Year High: $0.05
Propanc Biopharma, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 22 2019 | PPCB | Propanc Biopharma, ... | Kenyon Julian Norman | Chief Scientific Of ... | Option Exercise | A | 0.00 | 9,750,000 | 0 | 9,750,000 | |
May 22 2019 | PPCB | Propanc Biopharma, ... | Kenyon Julian Norman | Chief Scientific Of ... | Option Exercise | A | 0.00 | 9,750,000 | 0 | 9,750,000 | |
May 22 2019 | PPCB | Propanc Biopharma, ... | Kenyon Julian Norman | Chief Scientific Of ... | Option Exercise | A | 0.01 | 9,750,000 | 82,875 | 9,750,000 | |
May 17 2019 | PPCB | Propanc Biopharma, ... | Nathanielsz James Andrew | CEO, Acting CFO, Ch ... | Option Exercise | A | 0.00 | 19,500,000 | 0 | 19,500,000 | |
May 17 2019 | PPCB | Propanc Biopharma, ... | Nathanielsz James Andrew | CEO, Acting CFO, Ch ... | Option Exercise | A | 0.00 | 19,500,000 | 0 | 19,500,000 | |
May 17 2019 | PPCB | Propanc Biopharma, ... | Nathanielsz James Andrew | CEO, Acting CFO, Ch ... | Option Exercise | A | 0.01 | 19,500,000 | 183,300 | 19,500,000 | |
Sep 27 2016 | PPCH | Propanc Health Gro ... | Nathanielsz James Andrew | CEO, CFO, Secretary ... | Option Exercise | A | 0.03 | 71,500,000 | 2,145,000 | 71,500,000 | |
Sep 27 2016 | PPCH | Propanc Health Gro ... | Nathanielsz James Andrew | CEO, CFO, Secretary ... | Buy | J | 0.00 | 33,259,350 | 0 | 42,711,111 | 9.5 M to 42.7 M (+351.89 %) |
Sep 27 2016 | PPCH | Propanc Health Gro ... | Kenyon Julian Norman | Director | Option Exercise | A | 0.03 | 71,500,000 | 2,145,000 | 71,500,000 | |
Sep 27 2016 | PPCH | Propanc Health Gro ... | Kenyon Julian Norman | Director | Buy | J | 0.00 | 17,654,470 | 0 | 28,466,534 | 10.8 M to 28.5 M (+163.28 %) |
Jan 13 2015 | PPCH | Propanc Health Gro ... | Nathanielsz James Andrew | Chief Executive Off ... | Option Exercise | A | 0.00 | 500,000 | 0 | 500,000 | |
Jan 13 2015 | PPCH | Propanc Health Gro ... | Nathanielsz James Andrew | Chief Executive Off ... | Sell | S | 0.09 | 55,000 | 4,983 | 9,701,761 | 9.8 M to 9.7 M (-0.56 %) |
Jan 13 2015 | PPCH | Propanc Health Gro ... | Nathanielsz James Andrew | Chief Executive Off ... | Sell | S | 0.20 | 15,000 | 3,000 | 9,756,761 | 9.8 M to 9.8 M (-0.15 %) |
Jan 13 2015 | PPCH | Propanc Health Gro ... | Nathanielsz James Andrew | Chief Executive Off ... | Sell | S | 0.20 | 5,500 | 1,100 | 9,771,761 | 9.8 M to 9.8 M (-0.06 %) |
Jan 13 2015 | PPCH | Propanc Health Gro ... | Nathanielsz James Andrew | Chief Executive Off ... | Sell | S | 0.20 | 5,000 | 1,000 | 9,777,261 | 9.8 M to 9.8 M (-0.05 %) |